SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Champolion's Alternative Geron Corporation [NASDAQ: GERN]

No earlier versions found for this Subject.


Return to Champolion's Alternative Geron Corporation [NASDAQ: GERN]
 
Geron Corporation

230 Constitution Dr.
Menlo Park, CA 94025

Phone: 650-473-7700
Fax: 650-473-7701

geron.com

If Geron could turn back time, it would make a lot of money. The
company (which takes its name from the Greek word for old man)
conducts research on the aging process, focusing on telomeres,
structures that act as a molecular "clock" for cellular aging, and
telomerase, an enzyme that seems to prolong the cellular lifespan. By
creating a telomerase inhibitor, Geron hopes to allow the telomeres
of a cancerous cell to continue aging and eventually die. Its
research has applications to skin aging, osteoporosis, and
Alzheimer's disease. Geron has research collaborations with the
research groups at Johns Hopkins and University of Wisconsin that
discovered a method for culturing human stem cells.

Copyright © 1999, Hoover's, Inc.
Austin, Texas